title: [Lerkanidipin: evolution of dihydropyridine calcium antagonists continues].
abstract: We discuss the clinical studies on the efficacy and tolerability of lerkanidipine in arterial hypertension.
authors.forename: V V
authors.initials: VV
authors.lastname: Fomin
authors.forename: A A
authors.initials: AA
authors.lastname: Svistunov
mesh_terms: D000367:Age Factors; D000368:Aged; D050197:Atherosclerosis / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control*; D001794:Blood Pressure / Q000187:drug effects*; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000009:adverse effects; D059168:Carotid Intima-Media Thickness; D004095:Dihydropyridines / Q000008:administration & dosage / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring / Q000379:methods; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D060735:Pharmacovigilance; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D002121:Calcium Channel Blockers; D004095:Dihydropyridines; C060343:lercanidipine